Headquartered in The Biosphere, LightOx develops drugs and treatments for early-stage oral cancers, wound care… Continue Reading Q&A with LightOx

Study is designed to evaluate the safety and tolerability of increasing dose levels of the… Continue Reading Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2

Newcastle City Council is looking for an investor to accelerate the growth of the region's… Continue Reading NEWCASTLE ANNOUNCES LIFE SCIENCE INVESTOR OPPORTUNITY TO GROW SECTOR AND CREATE JOBS

The North East Innovation Lab, part of Newcastle Hospitals has achieved a major milestone with… Continue Reading North East Innovation Lab achieves UKAS accreditation in recognition of its high standards

Atelerix Limited, which develops and markets innovative solutions for the storage and transport of cells,… Continue Reading Atelerix Limited – Strategic partnership for market expansion

Technology disrupter CellRev have appointed Ralph Pickles, former executive at ICI, CEO of Quorn Foods,… Continue Reading CellRev appoint former Quorn Foods and ICI Executive to the board.

Alcyomics Limited® announces it is seeking partners toparticipate in validation tests of its unique in… Continue Reading Alcyomics® to Transform Drug Discovery for Osteoarthritis Treatment With Unique In Vitro Bio-Printed 3D Tissue Model.

Based at The Biosphere in Newcastle Helix, the facility is part of Newcastle Hospitals and… Continue Reading North east innovation lab celebrates two year anniversary supporting the development of cutting-edge diagnostics.

Launched at the height of the pandemic in January 2021, the North East Innovation Lab,… Continue Reading Case study: North East Innovation Lab

Based in The Biosphere since September 2020, AMLo Biosciences is a spin out company from… Continue Reading Case study: AMLo Biosciences